Comprehensive molecular biomarker identification in breast cancer brain metastases

BACKGROUND: Breast cancer brain metastases (BCBM) develop in about 20–30% of breast cancer (BC) patients. BCBM are associated with dismal prognosis not at least due to lack of valuable molecular therapeutic targets. The aim of the study was to identify new molecular biomarkers and targets in BCBM by...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Transl Med
Asıl Yazarlar: Schulten, Hans-Juergen, Bangash, Mohammed, Karim, Sajjad, Dallol, Ashraf, Hussein, Deema, Merdad, Adnan, Al-Thoubaity, Fatma K., Al-Maghrabi, Jaudah, Jamal, Awatif, Al-Ghamdi, Fahad, Choudhry, Hani, Baeesa, Saleh S., Chaudhary, Adeel G., Al-Qahtani, Mohammed H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5747948/
https://ncbi.nlm.nih.gov/pubmed/29287594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1370-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller